ITW
40
3
VRSK
32
2
M
53
-5
FOXA
66
2
WU
38
-9
APD
50
5
CF
41
-7
ROST
68
-3
LH
48
5
EXR
26
2
KSS
58
-4
DUK
55
3
PVH
30
-2
SJM
14
2
ACN
54
-2
RIG
43
3
DHI
37
-3
GD
64
2
VIX
19
-6
AAL
57
3
ITW
40
3
VRSK
32
2
M
53
-5
FOXA
66
2
WU
38
-9
APD
50
5
CF
41
-7
ROST
68
-3
LH
48
5
EXR
26
2
KSS
58
-4
DUK
55
3
PVH
30
-2
SJM
14
2
ACN
54
-2
RIG
43
3
DHI
37
-3
GD
64
2
VIX
19
-6
AAL
57
3
Financhill
Back

T Rowe Price Capital Appreciation Equity ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
35

TCAF
T Rowe Price Capital Appreciation Equity ETF

Last Price:
$38.44
Seasonality Move:
1.3%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
35
T Rowe Price Capital Appreciation Equity ETF (TCAF) is a Sell

Is T Rowe Price Capital Appreciation Equity ETF a Buy, Sell or Hold?

  • The current T Rowe Price Capital Appreciation Equity ETF [TCAF] share price is $38.43. The Score for TCAF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • TCAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCAF Stock Price Chart

What is T Rowe Price Capital Appreciation Equity ETF's stock price today?

  • The T Rowe Price Capital Appreciation Equity ETF share price today is $38.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCAF is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

TCAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 54.13 Buy
Chaikin Money Flow: 239800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.8 - 38.52) Buy
Bollinger Bands (100): (36.89 - 38.49) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

TCAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.07 Buy
20-day SMA: 38.27 Buy
50-day SMA: 38.31 Buy
200-day SMA: 35.56 Buy
8-day EMA: 24.14 Buy
20-day EMA: 12.54 Buy
50-day EMA: 5.62 Buy
200-day EMA: 1.49 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

T Rowe Price Capital Appreciation Equity ETF Earnings Growth & TCAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

T Rowe Price Capital Appreciation Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):